SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs rally is drawing attention to Morgan Stanleys bullish analyst view, the proposed Florida methane pipeline for higher-cadence Starship launches, and expectations around Starship Flight 15 and AI-related growth. Bulls are emphasizing momentum and possible short covering, while skeptics point to stretched valuation and upcoming share unlocks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Michael Caputos appointment to the Presidents Cancer Panel and his public engagement with ImmunityBios leadership are fueling speculation that Anktiva could gain broader access, alongside attention to the stocks high-volume breakout. Traders debate whether the move reflects that policy optimism or momentum and squeeze dynamics; broader access has not been confirmed.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs sharp rally is being linked by traders to speculation around a reported Russian plague-lab outbreak, alongside the Sanofi/Takeda rollout of its updated COVID vaccine. The community is split over whether the move reflects vaccine-commercialization optimism or outbreak-driven FOMO, with heavy short interest adding to short-squeeze speculation; a direct connection between the outbreak and Novavax business remains uncertain.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias breakout to record highs amid an AI-led technology rally is driving attention, with many traders celebrating the momentum and expecting it to continue. Others question the moves strength, citing light volume, elevated valuation and rising yields as reasons for caution or possible profit-taking.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgos reported OpenAI collaboration and push into autonomous, AI-enabled labs are driving renewed interest and a sharp rally, with bulls viewing the move as validation of its infrastructure pivot. Skeptics counter that the announcement has no disclosed financial value and that declining revenue and cash burn leave the business model unproven.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion centers on Trumps conditional $5,000 payment pledge if Republicans win both chambers, with many traders questioning its legality, funding, and credibility while some defend the proposal. Broader debate ties DJTs prospects to Trumps midterm standing amid criticism of the Iran war, fuel costs, and economic conditions.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Anticipation around Applied Digitals fiscal Q1 results and guidance is driving discussion, with traders debating whether lease revenue, project progress, or new contract and financing updates can improve sentiment. The confirmed addition of 75 MW at Polaris Forge 1 has reinforced the execution-focused bull case, but many remain frustrated that the shares have struggled amid weakness across data-center stocks and higher-rate concerns.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas planned Nasdaq-100 inclusion is drawing attention, with traders expecting index-tracking funds to buy shares and some attributing the rally to short covering. The move builds on optimism around the Merck-partnered melanoma vaccine trial, while bears argue the rally has outrun the companys fundamentals and valuation.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms renewed court fight with Arm over alleged licensing breaches and billions in potential royalties is driving attention, with traders linking the legal uncertainty to the stocks weakness. Some see risk that a judge could limit Qualcomms damages claim, while others focus on the possible upside if Qualcomm wins its bid to suspend royalty payments.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcytes VAX-31 met the primary goals in its pivotal Phase 3 adult pneumococcal-vaccine trial, driving a sharp rally as traders highlighted its potential to compete with existing vaccines. The announced equity-and-convertible-notes offering to fund further trials and launch preparation has prompted concerns about dilution, alongside bullish reactions to the clinical results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nasdaq 100 Hits Record Highs As Investors Shrug Off Pressure From Soaring Yields — NVDA, SPCX, CRML, TSLA, QCOM In Focus

Equity

The ISM report showed that the Purchasing Managers' Index for services came in at 54.9% in September, roughly in line with expectations.


Nvidia Gets Another AI Demand Signal As Foxconn Sales Hit Record High – Apple Faces Holiday Test

Foxconn said its Cloud and Networking Products business benefited from “strong pull-in momentum for AI products.”


LCRX Stock: Morgan Stanley Raises Price Target, Sees 50% Shipment Growth In 2026

According to TheFly, Morgan Stanley expects Lam Research’s leading logic-share gains to continue as it raises shipment-growth estimates and looks for a solid December quarter.

S&P 500, Nasdaq, Dow End Week Higher As Weak Jobs Report Cools Rate Hike Bets — NVDA, BA, SPCX, RIVN, APLD In Focus

The U.S. economy added 29,000 jobs last month, with unemployment rising to 4.2%, lower than what economists expected. 


NVDA Is ‘Best In Breed’ Stock On Sale, Hightower Advisors' Stephanie Link Says 

Market analysts highlight Nvidia as an attractive investment opportunity as its valuation drops to historic lows.

NVDA Stock Hits Record High After Morgan Stanley Names Nvidia Top Pick, Says AI Trends Play To Its ‘Strengths’

The firm maintained an ‘Overweight’ rating and a $300 price target on Nvidia.


The Semiconductor ETF's 2026 Return Is About 3 Times Nvidia's

Key PointsThe VanEck Semiconductor ETF was up around 69% in 2026 as of midday Sept. 30, but Nvidia shares were up about 23...

S&P 500, Nasdaq, Dow Futures Inch Higher As Investors Cheer Cooling Yields — GOOGL, MU, MAT, NVDA In Focus

10-year Treasury yields cooled off from the 2002 highs on Thursday.

Nvidia’s Hyperscaler Revenue Could Reach $401B In 2027, Says Analyst: SpaceX Could Push Barclays’ ‘Napkin Math’ Higher 

The math is based on Nvidia’s chart showing its share of IT capex at the five largest cloud service providers.


Micron CEO Says ‘We Cannot Fulfill The Demand’ As Supply Tightness Extends Through 2028

In an interview with CNBC, Mehrotra said some customer supply agreements now extend into 2031, giving Micron greater visibility into future demand and manufacturing needs.


VanEck ETF Trust - VanEck Semiconductor ETF

Neutral Sentiment

Too early to tell

Semiconductor stocks have been under significant selling pressure in recent weeks, leaving retail investors debating whether the worst is over or if more downside lies ahead. Cast your vote and let us know your reasoning in the comments.

Is the pullback in semiconductor stocks over? 
 
Explain your reasoning in the comments.

Current Price	$633.90
Prev Close	$630.60
Open	$631.47
Dividend Yield	N/A
50-Day Moving Average	$569.85
Beta	N/A
Avg. Volume	6.38M
PE Ratio	N/A

52-Week High	$671.83
52-Week Low	$315.05
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

SMH Fundamentals